TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms February 8, 1980
TCL Archive Epstein Alleges Conflict Of Interest Of Former Chairman And Sloan-Kettering Directors May 15, 1992
TCL Archive Gritz is president-elect of Society for Research on Nicotine and Tobacco. September 23, 2005
